higher - Denmark

Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity

Read More

Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity

2026-05-12

Early responders (15% or more weight loss after 24 weeks) to the higher dose of Wegovy® (semaglutide 7.2…

Orsted sees earnings tick higher in 'defining' year

Read More

Orsted sees earnings tick higher in ‘defining’ year

2026-02-06

Denmark’s Orsted posted a modest uptick in earnings on Friday following a “defining” year which saw it hit…